Addendum to the International Consensus Statement on testing and reporting of anti-neutrophil cytoplasmatic antibodies. Quality control guidelines, comments, and recommendations for testing in other autoimmune diseases
Savige J, Dimech W, Fritzler M, et al. Addendum to the International Consensus Statement on testing and reporting of anti-neutrophil cytoplasmatic antibodies. Quality control guidelines, comments, and recommendations for testing in other autoimmune diseases. Am J Clin Pathol 2003;120:312-4.
Evaulation of capture ELISA for detection of antineutrophil cytoplasmatic antibodies against proteinase-3 in Wegener's granulomatosis: First results from a multicenter study
Csernok E, Holle J, Hellmich B, et al. Evaulation of capture ELISA for detection of antineutrophil cytoplasmatic antibodies against proteinase-3 in Wegener's granulomatosis: first results from a multicenter study. Rheumatology 2004;43:174-80.
A novel high sensitivity ELISA for detection of antineutrophil cytoplasm antibodies against proteinase-3
Hellmich B, Csernok E, Fredenhagen G, et al. A novel high sensitivity ELISA for detection of antineutrophil cytoplasm antibodies against proteinase-3. Clin Exp Rheumatol 2007;25(1 Suppl 44):S1-5.
A critical evaluation of commercial immunoassays for antineutrophil cytoplasmatic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis
Csernok E, Ahlquist D, Ullrich S, et al. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmatic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis. Rheumatology 2002;41:1313-7.
ANCA in systemic vasculitides, collagen vascular diseases, rheumatic disorders and inflammatory bowel diseases
Hauschild S, Schmitt WH, Csernok E, et al. ANCA in systemic vasculitides, collagen vascular diseases, rheumatic disorders and inflammatory bowel diseases. Adv Exp Med Biol 1993;336:245-51.